Literature DB >> 15725342

Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin.

Tiziana Genovese1, Emanuela Mazzon, Carmelo Muià, Placido Bramanti, Angelina De Sarro, Salvatore Cuzzocrea.   

Abstract

Melatonin is the principal secretory product of the pineal gland and its role as an immuno-modulator is well established. Recent evidence shows that melatonin is a scavenger of oxyradicals and peroxynitrite and exerts protective effects in septic shock, hemorrhagic shock and inflammation. In the present study, we evaluated the effect of melatonin treatment, in a model of spinal cord injury (SCI). SCI was induced by the application of vascular clips (force of 50 g) to the dura via a four-level T5-T8 laminectomy. SCI in rats resulted in severe trauma characterized by edema, neutrophil infiltration and apoptosis (measured by terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling staining). Infiltration of spinal cord tissue with neutrophils (measured as increase in myeloperoxidase activity) was associated with enhanced lipid peroxidation (increased tissue levels of malondialdehyde). Immunohistochemical examination demonstrated a marked increase in immunoreactivity for nitrotyrosine and Poly(ADP-ribose) (PAR) in the spinal cord tissue. In contrast, the degree of (a) spinal cord inflammation and tissue injury (histological score), (b) nitrotyrosine and PAR formation, (c) neutrophils infiltration and (d) apoptosis was markedly reduced in spinal cord tissue obtained from rats treated with melatonin (50 mg/kg i.p., 30 min before SCI, 30 min, 6 hr, 12 hr and 24 hr after SCI). In a separate set of experiment we have clearly demonstrated that melatonin treatment significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, our results demonstrate that treatment with melatonin reduces the development of inflammation and tissue injury events associated with spinal cord trauma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15725342     DOI: 10.1111/j.1600-079X.2004.00194.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  24 in total

Review 1.  Antioxidant therapies for acute spinal cord injury.

Authors:  Edward D Hall
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

2.  Original Design of Fluorescent Ligands by Fusing BODIPY and Melatonin Neurohormone.

Authors:  Jérémy Thireau; Justine Marteaux; Philippe Delagrange; Francois Lefoulon; Laurence Dufourny; Gérald Guillaumet; Franck Suzenet
Journal:  ACS Med Chem Lett       Date:  2013-11-20       Impact factor: 4.345

3.  Oral administration of melatonin modulates the expression of tumor necrosis factor-α (TNF-α) gene in irradiated rat cervical spinal cord.

Authors:  Gholam Hassan Haddadi; Reza Fardid
Journal:  Rep Pract Oncol Radiother       Date:  2015-02-21

Review 4.  Inhibition of cysteine proteases in acute and chronic spinal cord injury.

Authors:  Swapan K Ray; Supriti Samantaray; Joshua A Smith; Denise D Matzelle; Arabinda Das; Naren L Banik
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

5.  Preconditioning of isoflurane on spinal cord ischemia can increase the number of inducible nitric oxide synthase-expressing motor neurons in rat.

Authors:  Yun-Hee Sung; Sang-Hak Lee; Joon-Kyung Sung; Jin-Hee Han; Hong Kim; Chang-Ju Kim; Jong-Man Kang
Journal:  Korean J Anesthesiol       Date:  2010-01-31

6.  PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury.

Authors:  I Paterniti; M Campolo; M Cordaro; D Impellizzeri; R Siracusa; R Crupi; E Esposito; S Cuzzocrea
Journal:  Mol Neurobiol       Date:  2016-09-29       Impact factor: 5.590

7.  Aquaporin 1 - a novel player in spinal cord injury.

Authors:  O Nesic; J Lee; G C Unabia; K Johnson; Z Ye; L Vergara; C E Hulsebosch; J R Perez-Polo
Journal:  J Neurochem       Date:  2008-01-28       Impact factor: 5.372

8.  Neuroprotective effects of high-dose vs low-dose melatonin after blunt sciatic nerve injury.

Authors:  Ghaffar Shokouhi; R Shane Tubbs; Mohammadali M Shoja; Shahram Hadidchi; Amir Ghorbanihaghjo; Leila Roshangar; Ramin M Farahani; Mehran Mesgari; W Jerry Oakes
Journal:  Childs Nerv Syst       Date:  2007-05-15       Impact factor: 1.475

9.  Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats.

Authors:  Supriti Samantaray; Eric A Sribnick; Arabinda Das; Varduhi H Knaryan; D Denise Matzelle; Anil V Yallapragada; Russel J Reiter; Swapan K Ray; Naren L Banik
Journal:  J Pineal Res       Date:  2007-12-13       Impact factor: 13.007

Review 10.  Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.

Authors:  Stefano Comai; Gabriella Gobbi
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.